Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acs.molpharmaceut.0c00371 http://scihub22266oqcxt.onion/10.1021/acs.molpharmaceut.0c00371 32379456!ä!32379456 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Pharm 2021 ; 18 (2): 476-482 Nephropedia Template TP {{tp|p=32379456|t=2021. Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection |pdf=|usr=}}{{32379456}} gab.com Text Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection JO: Mol Pharm http://www.kidney.de/pget.php?&tw=1&pmid=32379456 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 and COVID-19) has produced an unprecedented global pandemic. Though the death rate from COVID-19 infection is approximately 2%, many infected people recover at home. Among patients for whom COVID-19 is deadly are those with pre-existing comorbidities. Therefore, identification of populations at highest risk of COVID-19 mortality could significantly improve the capacity of healthcare providers to take early action and minimize the possibility of overwhelming care centers, which in turn would save many lives. Although several approaches have been used/developed (or are being developed/suggested) to diagnose COVID-19 infection, no approach is available/proposed for fast diagnosis of COVID-19 infections likely to be fatal. The central aim of this short perspective is to suggest a few possible nanobased technologies (i.e., protein corona sensor array and magnetic levitation) that could discriminate COVID-19-infected people while still in the early stages of infection who are at high risk of death. Such discrimination technologies would not only be useful in protecting health care centers from becoming overwhelmed but would also provide a powerful tool to better control possible future pandemics with a less social and economic burden. Twit Text FOAVip Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection ????Mol Pharm http://www.kidney.de/pget.php?&tw=1&pmid=32379456 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32379456 #FOAvip English Wikipedia <ref>{{Cite pmid|32379456}}</ref> Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection #MMPMID32379456 Mahmoudi M Mol Pharm 2021[Feb]; 18 (2): 476-482 PMID32379456show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 and COVID-19) has produced an unprecedented global pandemic. Though the death rate from COVID-19 infection is approximately 2%, many infected people recover at home. Among patients for whom COVID-19 is deadly are those with pre-existing comorbidities. Therefore, identification of populations at highest risk of COVID-19 mortality could significantly improve the capacity of healthcare providers to take early action and minimize the possibility of overwhelming care centers, which in turn would save many lives. Although several approaches have been used/developed (or are being developed/suggested) to diagnose COVID-19 infection, no approach is available/proposed for fast diagnosis of COVID-19 infections likely to be fatal. The central aim of this short perspective is to suggest a few possible nanobased technologies (i.e., protein corona sensor array and magnetic levitation) that could discriminate COVID-19-infected people while still in the early stages of infection who are at high risk of death. Such discrimination technologies would not only be useful in protecting health care centers from becoming overwhelmed but would also provide a powerful tool to better control possible future pandemics with a less social and economic burden. |COVID-19/*diagnosis/*mortality/*virology[MESH] |Humans[MESH] |Pandemics/statistics & numerical data[MESH] |Risk Factors[MESH]Emerging Biomolecular Testing to Assess the Risk of Mortality from COV(epmc).pdf DeepDyve Pubget Overpricing